+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07900542

Observational Study of Bloodstream Infections in Adults with Hematological Malignancies and Stem Cell Transplants Across the Middle East

Led by Hamad Medical Corporation · Updated on 2026-10-30

1000

Participants Needed

9

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a prospective observational study to understand bloodstream infections BSI in patients with hematological malignancies HM and recipients of hematopoietic stem cell transplants HSCT across the Middle East. The study aims to describe infection patterns, risk factors for inappropriate antimicrobial therapy, persistent infections, microbiological relapses, and overall mortality. This study is observational, with participants receiving standard care from their doctors. The study enrolls adults aged 18 and older from multiple centers in Qatar, Saudi Arabia, Oman, the United Arab Emirates, and Jordan who have HM or have undergone HSCT and then develop a bloodstream infection. Data collected includes patient demographics, clinical details, infection sources, laboratory findings, antimicrobial treatments, and critical care needs. Follow-up occurs for 30 days after the initial blood culture, with data securely recorded and managed by the principal investigator. Participants will have clinical and laboratory assessments during the 30-day follow-up, including microbiological evaluations. Researchers will measure the overall incidence of bloodstream infections per 1,000 patient days, persistent infections, microbiological relapse within 90 days, and mortality at 7, 14, and 30 days. The study uses statistical analysis to identify risk factors and outcomes, ensuring confidentiality and ethical oversight with a waiver of informed consent.

CONDITIONS

Brief Title

Middle East Study of Infections in Patients With Hematological Malignancies

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here